Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
38.9M
-
Shares change
-
+9.85M
-
Total reported value, excl. options
-
$2.42B
-
Value change
-
+$608M
-
Put/Call ratio
-
0.48
-
Number of buys
-
67
-
Number of sells
-
-29
-
Price
-
$62.32
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q1 2020
117 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q1 2020.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.9M shares
of 114M outstanding shares and own 33.96% of the company stock.
Largest 10 shareholders include Foresite Capital Management II, LLC (6.59M shares), Foresite Capital Management I, LLC (5.79M shares), MORGAN STANLEY (5.05M shares), SB INVESTMENT ADVISERS (UK) LTD (3.84M shares), FMR LLC (3.19M shares), ALLIANCEBERNSTEIN L.P. (1.57M shares), JS Capital Management LLC (1.41M shares), Invesco Ltd. (1.26M shares), VANGUARD GROUP INC (1.08M shares), and LORD, ABBETT & CO. LLC (789K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.